The Latest Breaking News from RBC Capital Markets

RBC Capital Markets has lowered Regeneron Pharmaceuticals Inc's price target (NASDAQ:REGN) from $679 to $647 and maintained a Sector Perform rating. Checks suggest that Dupixent (dupilumab) growth/durability should remain strong in new and existing indications, maintaining positive sentiment. The analysts also believe that the concerns about near-term Eylea competition may be overblown. However, high-dose…

RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the space could drive appreciation.

RBC Capital Markets views Tenet Healthcare Corp's (NYSE:THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds.  The analysts have raised the price target from $89 to $104 (41% upside) with an Outperform rating. Against an increasingly difficult labor backdrop characterized by high agency utilization, Tenet could hold…

Exxon Mobil Corp (NYSE: XOM) is the largest oil company by market capitalization and the biggest of the “Super-Majors,” which includes Chevron Corporation (NYSE: CVX), according to RBC Capital Markets.

Acadia Pharmaceuticals Inc (NASDAQ:ACAD) announced the primary endpoint miss of the phase 2 POC study of ACP-044 in acute postoperative pain following bunionectomy, a surgical procedure that moves toes back into the correct position.  RBC Capital Markets writes that although trends of pain reduction were observed in the 400 mg QID ACP-044 arm compared…

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a global leader in the robotic-assisted surgery market, which is not only large — it is estimated at more than $6 billion — but also the most underpenetrated and fastest-growing among the medical device sub-markets, according to RBC Capital Markets.

CSX Corporation’s (NASDAQ: CSX) stock has been under pressure due to its fourth-quarter results being less favorable than other companies in the industry, and its valuation has fallen “toward the lowest level relative to peers,” according to RBC Capital Markets.